{"schema_version":"1","generated_at":"2026-11-05T08:31:17.098Z","data_as_of":null,"url":"https://www.findmykol.com/kol/pamela-sung","json_url":"https://www.findmykol.com/kol/pamela-sung/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"pamela-sung","name":"Pamela Sung","credential":"MD, PhD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Roswell Park Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/roswell-park-comprehensive-cancer-center","city":"Buffalo","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1972862084","orcid":"0000-0002-5828-5622","openalex":"A5029064469"},"summary":"Pamela Sung is an Oncology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 36 publications with 270 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":36,"cited_by_count":270,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":687.94,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1972862084"},{"payer":"Daiichi Sankyo Inc.","program_year":2024,"amount_usd":7873.01,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1972862084"},{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2024,"amount_usd":143.43,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1972862084"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1972862084","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2021,"last":2024},"rows_total":4,"shown":3,"withheld":1,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08CA230190","title":"Improving targeted therapy in FLT3-mutated AML","fiscal_year":2024,"amount_usd":"194832","organization":"ROSWELL PARK CANCER INSTITUTE CORP","source_url":"https://reporter.nih.gov/quickSearch/K08CA230190"},{"project":"K08CA230190","title":"Improving targeted therapy in FLT3-mutated AML","fiscal_year":2023,"amount_usd":"192888","organization":"ROSWELL PARK CANCER INSTITUTE CORP","source_url":"https://reporter.nih.gov/quickSearch/K08CA230190"},{"project":"K08CA230190","title":"Improving targeted therapy in FLT3-mutated AML","fiscal_year":2022,"amount_usd":"192024","organization":"ROSWELL PARK CANCER INSTITUTE CORP","source_url":"https://reporter.nih.gov/quickSearch/K08CA230190"}],"source":"grants"},"publications":{"total":36,"shown":5,"withheld":31,"matched_by":"OpenAlex author record","recent":[{"title":"A novel BCR::ABL1 I502T mutation associated with acquired asciminib resistance in CML","year":2026,"journal":"Leukemia Research","source_url":"https://doi.org/10.1016/j.leukres.2026.108335","status":"verified"},{"title":"Abstract 7107: Dual FLT3/BRAF inhibitor PHI3 overcomes RAS-driven resistance in FLT3-mutant AML","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2026-7107","status":"verified"},{"title":"Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response","year":2025,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-025-02668-6","status":"verified"},{"title":"Novel Inhibitors for MDM2-MDM4 E3 Ligase Potently Induce p53-Indepedent Apoptosis in Drug-Resistant Leukemic Cells","year":2025,"journal":"Molecules","source_url":"https://doi.org/10.3390/molecules30010186","status":"verified"},{"title":"Combined FLT3 and EZH1/2 inhibition reduces LSCs and promotes myeloid differentiation in PDX models of AML","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-1488","status":"verified"}],"source":"works"},"contact":{"address_1":"ELM AND CARLTON STREETS","city":"Buffalo","state":"NY","zip":"142630001","phone":"716-845-2300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1972862084","source":"identity"},"similar":[{"name":"Igor Puzanov","slug":"igor-puzanov","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/igor-puzanov","json_url":"https://www.findmykol.com/kol/igor-puzanov/profile.json"},{"name":"Philip McCarthy","slug":"philip-mccarthy","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/philip-mccarthy","json_url":"https://www.findmykol.com/kol/philip-mccarthy/profile.json"},{"name":"Saby George","slug":"saby-george","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/saby-george","json_url":"https://www.findmykol.com/kol/saby-george/profile.json"},{"name":"Eunice Wang","slug":"eunice-wang","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/eunice-wang","json_url":"https://www.findmykol.com/kol/eunice-wang/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"funding":1,"publications":31}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-05-05","provider_certified":"2021-05-05","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}